SOUTHAMPTON UNIVERSITY HOSPITALS NHS TRUST. Corporate Monitoring Report. Alastair Matthews, Director of Finance

Similar documents
UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST. Finance Report. Paul Goddard, Assistant Director of Finance

Catherine Phillips, Director of Finance Sarah Elsey, Interim Head of Financial Management

Integrated Performance Report M Executive Summary

29th September Spencer Prosser, Chief Financial Officer. Bill Stronach, Deputy Chief Financial Officer. Finance Report Month /17

Agenda Item 9.1. Meeting / Committee. Meeting Date. 25 September Board of Directors. Information. This paper is for

2017/18 Month 3 Financial. Performance Report

Report. Chris Ford Joint Chief Finance Officer

Board Sponsor: Sarah Truelove, Director of Finance and Deputy Chief Executive. Author: Lynne Abbott, Head of Financial Management

SOUTHPORT & ORMSKIRK HOSPITAL NHS TRUST

2015/16 Financial Position to Month 1 - April. Author: [Lorraine Bentley] Sponsor: [Paul Traynor] Date: [Thursday 4 June 2015]

Board of Directors Meeting Report 25 May Agenda item 49/16

Report to the Merton Clinical Commissioning Group Governing Body

Jason Dorsett, Chief Finance Officer

2015/16 Financial Position (Month 2) Author: Lorraine Bentley Sponsor: Paul Traynor Date: Trust Board - Thursday 2 nd July 2015

Month 10 Finance Report

COST IMPROVEMENT PROGRAMME 2011/12 MONTH 6 REPORT

Integrated Quality, Performance and Finance Reporting Framework. Reporting period: Month 9 December 2014

0.1% > variance < 0.5% 0.1% > variance < 0.5% <95% but >= 50% of plan

SOUTHPORT & ORMSKIRK HOSPITAL NHS Trust

BOARD OF DIRECTORS COVER SHEET PART 1. DATE: 30 January Subject: CHARITABLE FUNDS EXPENDITURE OVER 25,000

TRUST BOARD PART I OCTOBER 2011 Agenda Item Number: 161/11 Enclosure Number: (3) Finance Report. Regular reporting. For information/awareness

Board of Directors Finance Presentation 2015/16. Friday 25th September 2015

For Assurance x For decision For discussion To note

The 2014/15 year to date (YTD) revenue position for GYW CCG is 1,565k surplus which is to plan.

Agenda Item 6.4 CCG Board EXECUTIVE SUMMARY SHEET

The Royal Wolverhampton NHS Trust

Understanding the financial position, financial forecasts and financial risk

Annual Financial Plan 2018/19. April 2018

SOMERSET PARTNERSHIP NHS FOUNDATION TRUST FINANCE REPORT. Report to the Trust Board 4 July 2018

345,780 Financed by: Taxpayers' Equity 360, , , ,617

Annual Audit Letter Southport and Ormskirk Hospital NHS Trust 13 July 2016

Report to: Public Trust Board Agenda item: 2.2 Date of Meeting: 12 May 2010

Kingston Hospital NHS Foundation Trust. Finance Report October 2018 (Month 07)

2017/18 Financial Plan and Budgets. John Ingham, Chief Finance Officer, NHS Norwich CCG. Discussion and Approval

Paper Finance Report. Month 9 (December 2015)

Title: NHS Funding Settlement Impact and Budget Setting 2018/19

Approve X Ratify For Discuss For Information X

The Royal Wolverhampton NHS Trust

Finance Report Period 6 September 2013

Trust Board Meeting 24th February 2011 FINANCE REPORT for the period ending 31st January 2011 (Month 10)

NHS Wandsworth Finance Report. For the period April 2012 November 2012 & Interim Report up to December 2012

Chief Finance Officer. The CCG reports a surplus of 79k for the year after holding a projected a surplus of 32k for the last three months.

UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST. Activity Management Monitoring

BOARD PAPER - NHS ENGLAND

EXECUTIVE SUMMARY. REPORT TO: Trust Board DATE: Thursday 3 January 2019 AGENDA NO: 3.1 AGENDA ITEM: Financial Report November 2018 SPONSOR:

3 February 2016 Enclosure H1

Board Meeting BOARD OFFICIAL

Nicci Briggs Director of Finance. Nicci Briggs Director of Finance PFR

NHS TRAFFORD CLINICAL COMMISSIONING GROUP GOVERNING BODY 24 April 2018

NHS financial sustainability

BNSSG CCG Governing Body Meeting

NHSGGC Revenue and Capital Report to 31 August 2018 (Paper 18/54) Board Official

Balanced year end position Remain within overall resources. Monthly Indicators Red Amber Green Total Year-end actual (Number of.

Agenda Item 7.3 CCG BOARD EXECUTIVE SUMMARY SHEET

Report. Date of Meeting: 6 th September 2018

Annual Audit Letter. Buckinghamshire Hospitals NHS Trust Audit 2008/09 September 2009

Finance Report: 2014/15 Month 9. Maria Moore Deputy Chief Executive/Director of Finance TRUST BOARD 29 th January 2015

Annual Audit Letter Year ending 31 March NHS Shropshire CCG 27 June 2018

2017/18 Quality, Innovation, Productivity and Prevention Programme

2 December In-Year Financial Position (excludes UHMB tariff modification impact)

The Annual Audit Letter for London North West Healthcare NHS Trust

Finance Assurance Report. March 2017

Finance Report M4 2016/17

Paper Finance Report. Month 11 (February 2016)

Kingston Hospital NHS Foundation Trust. Finance Report December 2017 (Month 09)

Board s corporate objectives for outline a requirement to provide best value for resources and deliver financial balance.

Trust Board Meeting: Wednesday 8 July 2015 TB Title Financial Performance to 31 May 2015

DATE: 14 th October 2016 Primary Care Co-Commissioning Due Diligence LEAD COMMITTEE MEMBER: Ahmet Koray, Chief Finance Officer (Islington CCG)

2017/18 Quality, Innovation, Productivity and Prevention Programme

The Annual Audit Letter for Leeds Teaching Hospitals NHS Trust

Finance Report, end of November 2015 (month eight)

BOARD PAPER - NHS ENGLAND

West Hertfordshire Hospitals NHS Trust. Finance Report. Period 12. April to March 2009

Norfolk Community Health and Care NHS Trust

George Eliot Hospital NHS Trust - Securing a sustainable future Project. Annex A

Annual Audit Letter. Hereford Hospitals NHS Trust Audit 2010/11

Date: 21 August 2018 Report Title: Finance monitoring report ( ) to 30 June 2018 Reference Number: Board Paper 2018/19/30

NHS LANARKSHIRE FINANCE REPORT FOR THE YEAR ENDED 31 MARCH 2006

PURPOSE OF REPORT: The purpose of this report is to provide an overview of the Trust s SLR performance for Month 10 of 2011/12.

EXECUTIVE SUMMARY EXECUTIVE SUMMARY

This report provides headlines of the finance and contracting position for the 12 months ended 31st March 2017.

Agenda Item: 4.4 Finance Report

NHS LOTHIAN APPENDIX 1 INTEGRATED JOINT BOARDS HOSTED SERVICES - FINANCIAL ASSURANCE AND RISK SHARING PROTOCOL

Finance Assurance Report. February 2017

Kingston Clinical Commissioning Group Report Summary

Corporate Performance Report 2015/16

Item 8iii. Draft financial Plan Document for Moorfields Eye Hospital NHS Foundation trust. Prepared by:

Finance Report March 2012

Capital Programme to

Trust Board Meeting: Wednesday 13 November 2013 TB

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY REPORT TO THE BOARD OF DIRECTORS 21 FEBRUARY 2018

NHS financial sustainability

Finance and Performance Committee

To: Trust Board From: Abi Tierney Director of Strategy Andrew Seddon Director of Finance & Procurement Date: 4 th February 2010 Healthcare standard:

Scottish Government Draft 2010/11 Budget Proposals. Response to the call for evidence from the Health and Sport Committee

healthcare; 6. To play an active and influential role in shaping SE London and London wide X commissioning.

The Annual Audit Letter for University Hospitals of North Midlands NHS Trust

Budget and Capital Plan 2018/19. This paper provides the Board with a summary of the indicative budget and capital plan approved by FIC for noting.

Western Health and Social Care Trust. Financial Performance Report

Board s corporate objectives for outline a requirement to provide best value for resources and deliver financial balance.

Transcription:

SOUTHAMPTON UNIVERSITY HOSPITALS NHS TRUST Report to: Trust Board 1 st July 2008 Corporate Monitoring Report Report from Sponsoring Executive: Purpose of Report: Review History to Date: Recommendation: Alastair Matthews, Director of Finance To update the Trust Board on the financial, activity and savings performance of the Trust for May 2008. The Trust Board has previously agreed the income and expenditure budgets for 2008/2009 with a full year plan surplus of 13.3m. The Board are asked to note: (1) In May, the Trust made a loss of 0.5m, compared to a planned deficit of 0.1m. The main driver for this has been clinical income, due to April s activity being some way below Production Plan. Enhanced monitoring and forecasting of income is being developed to identify and mitigate areas of shortfall. (2) Performance Improvement Programmes (PIPs) delivered were well below Plan, although some of the shortfall relates to profiling. Individual divisional reviews by the Chief Executive Officer, Director of Finance and Chief Operating Officer are in progress, to ensure full CIPs are identified, risks to delivery are minimised and to drive earlier delivery of savings. (3) There are still expenditure pressures within the Divisions, mainly due to unfound savings, that are being partially offset by the short-term management of discretionary spend and non-recurring benefits. The underlying financial position, therefore, remains a cause for some concern. The principal area of concern is the Unscheduled Care division, which is under special measures, with formal review meetings with the Chief Executive every two weeks. (4) The format of the CMR has been changed this month to more closely resemble the format of reporting to Monitor. Summary The Trust had a difficult month in May, delivering a loss of 0.4m, a bigger loss than planned, although this was largely driven by April s activity performance. Cumulatively the Trust has made a surplus of 0.3m, compared to a Planned surplus of 0.6m. There are continuing spend pressures within the Hospitals, partially offset by short term reductions in discretionary spend and non-recurring benefits in non-pay spend. Due to the time lag in activity information being available (1 month in arrears), central income is based on April s activity, which was some way below Production Plan levels although higher than contracted levels (the Sales Plan). Some of the cumulative variance of 0.7m will be down to the fact that the Production Plan is phased in twelfths, even though some of the anticipated growth is towards the end of the year. Work is being carried out to identify the impact of this phasing. The Divisions and Headquarters functions underspent by 0.4m in the month. The 1

underlying expenditure position continues to be difficult due to continuing agency cost pressures particularly in Division 2 (unscheduled care) and the phasing and level of identified PIPs. These pressures have been offset to a degree by shortterm reductions in discretionary spend and other non-recurring benefits. Savings delivered (PIPs) were 1.2m short of their budgeted level although 0.6m of this was due to phasing budgets in twelfths; the shortfall against what the Divisions had said they would deliver in terms of savings was 0.6m. At the end of April the Trust had 19.4m in the bank. This represents an increase of 3m compared to last month and is largely down to the fact that a lower value of invoices was received for payment in the month. Key Messages for May: Delivery of the Trust s financial targets in 2008/2009 will be determined by performance in four areas, as follows: a) Divisional and Headquarter Directorates controlling expenditure to within their budgetary runrate targets. b) Delivery of in-year financial savings of at least 17.7m. c) Achievement of sufficient activity levels to secure the income levels planned. d) Development of a contingency reserve to offset any unexpected variations on the above, and to manage the risks associated with performance related fines, Demand Management and the Independent Sector Treatment Centre. (ISTC) This report provides an update on these four areas. a) Controlling of expenditure to within the agreed runrate budget targets In overall terms the Trust is cumulatively underspent against its forecast expenditure by 0.5m, as shown on schedule 6. In total Clinical Directorates are 1.1m above Plan and Headquarters Directorates and central areas are 1.6m below. Of the cumulative variance, there is a 1.6m underspend against runrate budgets, offset by slipped and unrealised savings of 0.6m. A further 0.6m variance is due to the fact that PIP targets are phased in twelfths. Divisional performance is analysed on Schedule 6. Division 1 (surgery) overspent against its budgets by 77k in May (cumulatively 115k overspent). Unfound PIP savings were partially offset by savings on discretionary / nonpay costs. In May Division 2 (unscheduled care) overspent by 514k (cumulatively 1,103k overspent). The main pressures continue to arise from premia on agency staff and premium overtime rates ( 272k in month) and unfound savings. Private patient income in Cancer Care also continues to under recover ( 55k in month). Due to the Division s ongoing problems with capacity and recruitment, the Division remains under Special Measures to ensure that the current problems are addressed as rapidly as possible. It is expected that the staffing related issues, whilst subject to a detailed action plan and monitoring, will lead to 2.4m being drawn on contingency reserves for the full year. Divisions 3 (women and children) and 5 (diagnostics and therapies) narrowly failed to meet their expenditure targets in May, mainly due to slippage on PIPs. Division 4 (specialist services) underspent slightly mainly due to lower than planned activity. Divisional income had an adverse variance of 504k in May; this was due to realigning income and spend budgets for hosted services and there is a positive variance of the same amount in spend budgets. 2

Headquarters and central budgets collectively underspent by 1,538k in May. Two months worth of the trust's contingency reserves ( 500k) have been released in month to support the financial position and there is a 561k benefit on hosted services (with a corresponding underecovery of income see above). Slippage on the delivery of savings of 93k was offset by staff vacancies, underspends on consultancy budgets and overrecovery of RTA income. b) Delivering an in-year financial saving of 17.7m At the end of May savings of 1.1m had been delivered, compared to the Plan of 2.3m. Of the variance of 1.2m, 0.6m relates to unidentified savings and differences in profiling between budgets and the savings profile the Divisions are working to. Schedule 7 shows the analysis of firm plans by Divisions, Headquarters Directorates and central schemes and Schedule 8 shows the detail of the overall savings programme of 17.7m. Significant efforts are underway in divisions, facilitated by the PMO, to improve the situation. At the end of May 14.2m (80%) of specific schemes had been identified. By mid-june this had increased to 15.8m (89%), with a higher proportion of schemes identified as green in terms of risk of delivery. Formal reviews are scheduled for divisions with the Chief Executive and Finance Director during June and early July, aimed specifically at fully identifying the programme and driving earlier delivery of some schemes. c) Achieving the agreed volumes of activity to deliver the income plan Activity figures for April are now available and they show underperformance compared to the Production Plan of 1.1m. Early signs for May also suggest a low activity month but not to the same extent. These underperformances are offset by additional activity from March, which was not identified in time to be billed in the old financial year ( 675k). As a result of these factors NHS Clinical Income is estimated to be 6777k underrecovered at the end of May. Non NHS Clinical Income shows an adverse variance of 286k cumulatively, due to lower than Plan private patient income. Detailed variances by commissioner are shown on Schedule 3. In future the CMR will also include a Schedule 4, showing income by type (elective, nonelective etc). This data is not yet available for May. d) Creation of a contingency to cover unexpected variations on the above The approach for 2008/09 has been based on identifying contingency reserves to cover the likely risk from variations in costs against Plan, contractual fines, the ISTC, Extended Choice and Demand Management. If risks are successfully managed out, these reserves will become available to put into the central bank to which bids for funding to improve services, quality and the hospital environment, can be made. In May two twelfths ( 500k) of the Trust s uncommitted reserves were released to the bottom line. Cash and liquidity Schedules 9a and 10 show the Trust s current balance sheet and cashflow. The Trust s cash position has improved considerably over the last 18 months, although this was only achieved by taking out a 25m working capital loan from the Department of Health last year and 10.5m of capital loan in 2007/08, on which interest is payable. 3

At the end of May the Trust had 19.3m in the bank and is now paying over 90% of non-nhs suppliers within 30 days. The increase in cash in month is largely due to the timing of payments to creditors. Payment runs were low in month although there has not been an increase in unpaid bills in the system. Debtors fell considerably due to the recoding of unallocated cash balances. Assuming a 30 day working capital facility was in place, the current financial position would result in a liquidity rating of 4 and an overall Monitor risk rating of 4. (Schedule 2a). Schedule 2a also shows some key balance sheet indicators which we are developing. Non-NHS trade debtor days (NHS debtors divided by NHS income, expressed as a number of days) are significantly lower than forecast and trade creditor days are higher. These variances are currently being investigated, and planned numbers for each month are currently being calculated. Schedule 11 shows capital expenditure for the year to date compared to Plan. Thus far, 2.3m has been spent against a Plan of 3.4m. Risks The Trust s main financial risks are summarised below. The approach this year has been to identify contingency reserves to manage the risks associated with performance related fines, Demand Management and the Independent Sector Treatment Centre (ISTC) as well as general cost pressures and non-delivery of the Production Plan. Currently, reserves of 16m are being held, of which 500k has been released to support the financial position in May. Risks Identified Income & Contracts Description The level of contracted income is lower than that assumed in the Production Plan Potential for challenges to SUHT coding beyond the 1m held in Reserves MFF Lower than planned due to MFFable income under PbR being lower Penalty regime under mandated national contracts Lose more activity than anticipated due to Choice/ISTC Potential Value m Likelihood 4 Weighted value m Mitigation 17.0 L 25% 4.3 Ensure that the Trust works to full capacity and that additional work flows into the Trust as expected. Have clear mechanisms for cost reduction should the income not flow. This is of particular concern based on month 1 but it is too early to draw firm conclusions at this stage. 1.0 L 25% 0.3 Risk capped under the contract at 1m per PCT. Need a robust process to identify and prevent inappropriate zero length of stay admissions 1.0 L 25% 0.3 Monitor level of PbR activity; provide for this from any over performance 11.0 M 50% 5.5 Ensure the Trust complies with service performance (C difficile, 18 weeks) and information provision requirements; increase CIPS; utilise contingency reserves 2.5 M 50% 1.3 Seek other clinical income by increasing market share in targeted areas; increase CIPs CIPs Non-delivery of CIPs 5.0 M 50% 2.5 Seek CIPs in other areas; slip developments Demand Cost reduction 5.0 M 50% 2.5 Model and understand costs which Managem required in response to can be removed; increase CIPs;

ent successful Demand Management Subcontracting required if Demand Management fails ISTC Inability to reduce costs Divisional overspen ding Pressures experienced in 07/08, principally in Division 2, flow through into 08/09 develop new income streams to compensate 2.0 M 50% 1.0 Work with PCTs to develop robust Demand Management plans which enable the Trust to move to optimal capacity 2.5 M 50% 1.3 Model and understand costs which can be removed; increase CIPs; develop new income streams to compensate 5.0 L 25% 1.3 Set budgets at outturn run rate levels and based on a realistic capacity plan TOTAL 20.3 5